iShares Global Healthcare ETF (IXJ)
111.88
-0.78 -0.69%
NYSE Arca
Apr 20, 20:00
Delayed 2m
USD
IXJ Key Stats
| Net Asset Value | Upgrade |
| Discount or Premium to NAV | Upgrade |
| Turnover Ratio | Upgrade |
View All IXJ News
IXJ News
-
WireHeadlineTime (ET)
-
Yahoo04/13 09:35
-
Yahoo04/04 10:33
-
SA Breaking News04/04 07:59
-
SA Breaking News04/02 08:10
-
Yahoo04/02 07:30
-
Yahoo04/02 07:30
-
Business Wire03/29 16:30
-
Yahoo03/15 16:50
-
SA Breaking News03/15 15:59
-
Yahoo03/07 10:31
IXJ Performance
| Total Return (Price) | Total Return (NAV) | Cat. Total Return (NAV) | % Rank in Cat. (NAV) | |
|---|---|---|---|---|
| 1M | -1.78% | -1.55% | -1.63% | 29 |
| 3M | -5.81% | -5.59% | -2.73% | 71 |
| 6M | -1.76% | -1.52% | 3.05% | 73 |
| YTD | -0.57% | -0.44% | 3.13% | 76 |
| 1Y | 10.84% | 11.09% | 17.47% | 65 |
| 3Y | 2.67% | 2.75% | 3.10% | 53 |
| 5Y | 10.04% | 10.12% | 14.14% | 85 |
| 10Y | 10.00% | 9.99% | 13.17% | 93 |
IXJ Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | 0.35% | 0.35% | 0.00% |
| Stock | 99.65% | 99.65% | 0.00% |
| Bond | 0.00% | 0.00% | 0.00% |
| Convertible | 0.00% | 0.00% | 0.00% |
| Preferred | 0.00% | 0.00% | 0.00% |
| Other | 0.00% | 0.00% | 0.00% |
IXJ Region Exposure
| Americas | 69.54% |
| North America | 69.54% |
| Latin America | 0.00% |
| Greater Europe | 23.34% |
| United Kingdom | 4.43% |
| Europe Developed | 18.91% |
| Europe Emerging | 0.00% |
| Africa/Middle East | 0.00% |
| Greater Asia | 7.12% |
| Japan | 5.33% |
| Australasia | 1.79% |
| Asia Developed | 0.00% |
| Asia Emerging | 0.00% |
| Market Classification | |
| % Developed Markets | 100.00% |
| % Emerging Markets | 0.00% |
IXJ Stock Sector Exposure
| Basic Materials | 0.00% |
| Communication Services | 0.00% |
| Consumer Cyclical | 0.00% |
| Consumer Defensive | 0.00% |
| Energy | 0.00% |
| Financial Services | 0.00% |
| Healthcare | 99.13% |
| Industrials | 0.00% |
| Real Estate | 0.00% |
| Technology | 0.87% |
| Utilities | 0.00% |
IXJ Stock Market Capitalization
| Giant | 59.89% |
| Large | 35.94% |
| Medium | 4.18% |
| Small | 0.00% |
| Micro | 0.00% |
IXJ Stock Style Exposure
| Large Cap Value | 35.67% |
| Large Cap Blend | 27.47% |
| Large Cap Growth | 32.68% |
| Mid Cap Value | 0.68% |
| Mid Cap Blend | 1.97% |
| Mid Cap Growth | 1.52% |
| Small Cap Value | 0.00% |
| Small Cap Blend | 0.00% |
| Small Cap Growth | 0.00% |
View More Holdings
As of April 19, 2018
IXJ Top 10 Holdings
| Symbol | Name | % Weight | Price | % Chg |
|---|---|---|---|---|
| JNJ | Johnson & Johnson | 7.37% | 126.66 | -0.70% |
| UNH | UnitedHealth Group Inc | 4.92% | 235.06 | -0.30% |
| PFE | Pfizer Inc | 4.68% | 36.63 | +0.27% |
| NOVN | Novartis AG | 4.51% | -- | -- |
| MRK | Merck & Co Inc | 3.40% | 58.83 | +0.32% |
| ROG | Roche Holding AG Dividend Right Cert. | 3.39% | -- | -- |
| ABBV | AbbVie Inc | 3.23% | 92.60 | -0.44% |
| AMGN | Amgen Inc | 2.49% | 171.56 | -0.79% |
| MDT | Medtronic PLC | 2.33% | 79.90 | -0.12% |
| ABT | Abbott Laboratories | 2.26% | 59.19 | -1.15% |
Advertisement
IXJ One Page Reports
- One Page Report Download
IXJ Basic Info
| Style | |
|---|---|
| Equity Style | Large Cap/Blend |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Health |
| Prospectus Objective | Specialty - Health |
| Fund Owner Firm Name | iShares |
| Benchmark Index | |
|---|---|
S&P Global 1200 Healthcare Sector NR USD |
100.0% |
IXJ Manager Info
| Name | Tenure |
|---|---|
| Alan Mason | 1.71 yrs |
| Diane Hsiung | 10.01 yrs |
| Greg Savage | 10.01 yrs |
| Jennifer Hsui | 5.42 yrs |
IXJ Net Fund Flows
| 1M | -6.028M |
| 3M | -16.28M |
| 6M | -15.88M |
| YTD | -16.28M |
| 1Y | -27.05M |
| 3Y | -142.06M |
| 5Y | 367.95M |
| 10Y | 336.74M |
IXJ Risk Info
| Beta (5Y) | 0.8892 |
| Max Drawdown (All) | 40.60% |
| Historical Sharpe (10Y) | 0.7563 |
| Historical Sortino (All) | 0.6697 |
| 30-Day Rolling Volatility | 17.63% |
| Daily Value at Risk (VaR) 1% (All) | 3.00% |
| Monthly Value at Risk (VaR) 1% (All) | 11.58% |
IXJ Fundamentals
| Dividend Yield TTM (4-20-18) | 1.47% |
| SEC Yield (12-31-15) | 1.42% |
| Weighted Average PE Ratio | 25.22 |
| Weighted Average Price to Sales Ratio | 2.073 |
| Weighted Average Price to Book Ratio | 3.514 |
| Weighted Median ROE | 20.29% |
| Weighted Median ROA | 6.81% |
| Forecasted Dividend Yield | 2.17% |
| Forecasted PE Ratio | 15.70 |
| Forecasted Price to Sales Ratio | 1.943 |
| Forecasted Price to Book Ratio | 3.247 |
| Number of Holdings | 110 |
IXJ Growth Estimates
| Forecasted 5 Yr Earnings Growth | 9.60% |
| Forecasted Book Value Growth | 7.19% |
| Forecasted Cash Flow Growth | 8.18% |
| Forecasted Earnings Growth | 0.94% |
| Forecasted Revenue Growth | 7.00% |
IXJ Attributes
| Key Dates | |
|---|---|
| Inception Date | 11/13/2001 |
| Termination Date | |
| Last Annual Report Date | 3/31/2017 |
| Last Prospectus Date | 9/30/2017 |
| Attributes | |
| Exchange Traded Share | Yes |
| Exchange Traded Note | No |
| Enhanced Index Fund | No |
| Index Fund | Yes |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| General Availability | |
| Available for Insurance Product | No |
| Available for Retirement Plan | No |
| Available for RRSP | No |
IXJ Excel Add-In Codes
- Name: =YCI("IXJ","name")
- Broad Asset Class: =YCI("IXJ", "broad_asset_class")
- Broad Category: =YCI("IXJ", "broad_category_group")
- Prospectus Objective: =YCI("IXJ", "prospectus_objective")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Advertisement
